G6PD Deficiency and Hemoglobinopathies

This entry groups two large families of inherited red-cell disorders that cause hemolysis through intrinsic defects: glucose-6-phosphate dehydrogenase (G6PD) deficiency, an enzymopathy that impairs the red cell's defense against oxidative stress, and the hemoglobinopathies, in which structural or quantitative hemoglobin abnormalities shorten red-cell survival. Both are far more common in regions where malaria is or was endemic.

Definition

G6PD deficiency is an X-linked enzymopathy that reduces red-cell protection against oxidative damage, predisposing to acute hemolysis under oxidative stress; hemoglobinopathies are inherited disorders of hemoglobin structure or synthesis that can themselves cause or contribute to hemolytic anemia.

Scope

The entry covers the biochemical basis of G6PD deficiency and the resulting episodic, oxidant-triggered hemolysis, and it orients the reader to the hemoglobinopathies as a category of hemoglobin-based red-cell disorders. It is a reference and classification topic; it does not list trigger agents to avoid or provide management or dosing advice.

Core questions

• How does loss of G6PD activity leave the red cell vulnerable to oxidative injury?
• Why is the hemolysis of G6PD deficiency typically episodic rather than continuous?
• How do structural and quantitative hemoglobin abnormalities lead to shortened red-cell survival?

Key concepts

• Glucose-6-phosphate dehydrogenase
• Pentose phosphate pathway and NADPH
• Oxidative stress and red-cell defense
• Heinz bodies and bite cells
• Episodic (oxidant-triggered) hemolysis
• X-linked inheritance
• Hemoglobinopathies
• Malaria selection (balanced polymorphism)

Mechanisms

G6PD catalyzes the first step of the pentose phosphate pathway, generating NADPH that maintains reduced glutathione, the red cell's principal defense against oxidative damage. When enzyme activity is deficient, oxidative stress overwhelms this defense, hemoglobin is oxidized and precipitates as Heinz bodies, and the damaged cells are removed, producing acute, often episodic intravascular and extravascular hemolysis (luzzatto-2020, cappellini-2008). Because young red cells have higher residual enzyme activity, hemolysis is frequently self-limited as the older, most-deficient cells are cleared (luzzatto-2020). In the hemoglobinopathies, abnormal hemoglobin structure or imbalanced globin-chain synthesis destabilizes the red cell and contributes to hemolysis; the shared hemolytic laboratory markers reflect the accelerated turnover (barcellini-2015).

Clinical relevance

G6PD deficiency and the hemoglobinopathies are leading inherited causes of hemolytic anemia worldwide and exemplify how an enzyme or hemoglobin defect translates into shortened red-cell survival. This entry describes their mechanisms and classification for reference and educational purposes and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

G6PD deficiency is one of the most common human enzyme defects, affecting hundreds of millions of people, with highest frequencies in parts of Africa, the Mediterranean, the Middle East, and Asia — a distribution attributed to a survival advantage against malaria (luzzatto-2020, cappellini-2008). Hemoglobinopathies show a comparable geographic concentration in historically malaria-endemic regions.

Evidence & guidelines

Comprehensive narrative reviews describe the biochemistry, genetics, and clinical spectrum of G6PD deficiency (luzzatto-2020, cappellini-2008), and reviews of hemolytic markers situate enzyme- and hemoglobin-related hemolysis within the wider differential (barcellini-2015); these are descriptive references rather than prescriptive instructions.

Seminal works

• luzzatto-2020
• cappellini-2008

Frequently asked questions

Why does G6PD deficiency cause hemolysis only intermittently?

The red cell tolerates normal conditions but cannot cope with added oxidative stress; hemolysis is typically triggered by oxidant exposure and is often self-limited because newer red cells retain more enzyme activity than older ones.

Why are G6PD deficiency and hemoglobinopathies common in the same regions?

Both are concentrated in historically malaria-endemic areas, where carrying the trait is thought to confer some protection against severe malaria, a classic example of a balanced genetic polymorphism.